2020 ASCO Virtual Direct™ Highlights


 

Olaparib Efficacy in Recurrent Ovarian Cancer: Is There OS Improvement With Maintenance Olaparib in Platinum-Sensitive BRCA+ Patients?

43 views
February 2, 2021
Comments 0
Login to view comments. Click here to Login